![](/img/cover-not-exists.png)
Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers
Yap, T. A., Yan, L., Patnaik, A., Tunariu, N., Biondo, A., Fearen, I., Papadopoulos, K. P., Olmos, D., Baird, R., Delgado, L., Tetteh, E., Beckman, R. A., Lupinacci, L., Riisnaes, R., Decordova, S., HVolume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-0868
Date:
November, 2014
File:
PDF, 693 KB
english, 2014